Academia.eduAcademia.edu

Lessons learnt from the Uganda smallholder pigs value chains

2021

Abstract

Conclusions and Recommendations 2 Smallholder pig value chains in Uganda: An introduction 2.1 Pig production demographics 2.2 Importance of pig keeping 2.3 Pig population density and geographic distribution 2.4 Pig production systems 2.4.1 Pig production types 2.4.2 Pig Keeping systems 2.4.3 Pig husbandry practices 2.4.4 Pig disease burden 2.4.5 Animal health service suppliers 2.5 Marketing and value chain governance 2.6 Animal health service delivery and extension services 2.7 Gender and pig production 2.8 Pig slaughter and pork consumption 2.9 Pig value chain's constraints 2.9.1 Production level 2.9.2 Health input supply level 2.9.3 Trading/Marketing 2.9.4 Quality control 2.9.5 Policy 3 Porcine cysticercosis in Uganda: Background and status 3.1 Prevalence and risk factors of porcine cysticercosis in Uganda 3.2 Human health perspectives on porcine cysticercosis 3.3 Control measures for porcine cysticercosis 9 Discussion 9.1 Methods to support adoption of the TSOL18 vaccine-oxfendazole combination 9.1.1 Willingness to pay 9.1.2 Product distribution 9.1.3 Cost of the product 6 9.1.4 Formulation of the vaccine 9.1.5 Public or private good? 9.2 Roles of sensitisation in the uptake of the product 9.3 Actors' roles in creating a cost-effective, sustainable process 10 Recommendations 10.1 Marketing the vaccine as a private or public good 10.2 Marketing opportunities and barriers 10.2.1 Market entry points 10.2.2 Barriers to market entry 10.3 Sensitisation approaches and materials needed 10.4 Key opportunities and challenges 10.5 Key interventions to improve livelihoods for resource-limited stakeholders 10.6 Relevant policy issues that enhance or hamper TSOL18 vaccine delivery Annex 1: Distribution of 90% of the pig population per district Annex 2: Prevalence studies on porcine cysticercosis in Uganda Annex 3: Cards with pictorial profiles describing the differences in traits and the levels to demonstrate each choice set to survey respondents-pig farmers Annex 4: Questionnaire covered socioeconomic aspects such as location of the farm and other household and farm level characteristics Annex 5: Questionnaire on pig farmer's willingness to pay for porcine cysticercosis vaccine (TSOL 18 vaccine-oxfendazole) Annex 6: Questionnaire on Uganda pig traders willingness to pay for porcine cysticercosis vaccinated pigs Annex 7: Guideline for Focus Group Discussion on Uganda consumers' perceptions on animal source foods safety Annex 8: Guideline for Focus Group Discussion on Uganda pork consumers' perceptions on pork safety, with a focus on porcine cysticercosis-free pork Annex 9: Questionnaire for animal health service providers on pig farmer use of wormers and willingness to sell TSOL 18 and oxfendazole Annex 10: Tool for product profiling (TSOL 18 vaccine and oxfendazole 10% (PARANTHIC) Annex 11: Tool for key informant interviews with veterinary drug and vaccine importers in Uganda Annex 12: Guideline for stakeholder discussion on recommendations on the potential for large scale sustainable private sector distribution mechanisms of TSOL 18 vaccines in Uganda. Annex 13: Study consent forms Annex 14: Images and photos References • For the TSOL18 vaccine-oxfendazole combination to be competitive (if viewed simply as a de-wormer), it should be priced between US$1.62 and US$6.11, per the drug stockist scoping study. • Even though oxfendazole is comparatively expensive, there is an opportunity for it to capture some market share because it is a broad-spectrum de-wormer on top of being effective against porcine cysticercosis. However, the fact that the vaccine and de-wormers are not packaged together makes the combination unattractive to distributors because of anticipated challenges in acquiring both products at the same time when needed. Conclusions and Recommendations Insights from the market scoping study shows that obtaining a premium price for immunized pigs is a strong incentive for farmers to vaccinate pigs for porcine cysticercosis. Additionally, the demonstrated preference for the TSOL18 vaccine with low administration costs (US$0.90 per pig) underscores a communal approach and preference for a one-dose TSOL18 vaccine. However, quality assurance is a concern for pig farmers, as expressed in their preference for a viability detector; the product manufacturer should take this into account. The TSOL18 vaccine-oxfendazole combination as presented is less likely to succeed as a private good. In addition, there is need for mass sensitisation about the control of T. solium cysticerciosis amongst stakeholders at all levels (including veterinarians, farmers, traders, butchers, consumers, animal health service providers, and policymakers). Necessary accompanying intervention measures along the value chain would include: Animal health service providers: They are the major source of information for farmers. So, they represent an important channel for information dissemination to farmers. During awareness campaigns, the animal health service providers should be involved. They should also be trained in disease recognition and management of carcasses that are affected. Farmers: The product packaging and cost of the TSOL18 vaccine-oxfendazole combination should be addressed so that farmers can easily purchase it. Farmers should be sensitised about the effects of the disease on pigs and its public health importance.